A Randomized, Observer-Masked, Parallel-Group, Multicenter Trial Evaluating the Ocular Penetration of 1.5% Levofloxacin Ophthalmic Solution and 0.5% Moxifloxacin Ophthalmic Solution in Subjects Undergoing Corneal Transplant Surgery.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2009
At a glance
- Drugs Levofloxacin; Moxifloxacin
- Indications Bacterial infections; Postoperative infections
- Focus Pharmacokinetics
- Sponsors Santen Pharmaceutical
- 28 Aug 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Oct 2008 New trial record.